ssp-19 Antibody

Shipped with Ice Packs
In Stock

Description

Possible Interpretations of "SSP-19 Antibody"

The term "SSP-19" could refer to:

  • Streptococcal-Specific Protein (SSP)-Related Antibodies: In systemic lupus erythematosus (SLE) research, anti-SSP antibodies target commensal Streptococcus mutans proteins, potentially linking bacterial exposure to autoimmune responses . A study identified a novel mitochondrial immuno-dominant protein (MIP) with a P32–55 epitope as a key target in SLE .

  • SARS-CoV-2 Spike Protein (S) Epitopes: While no "SSP-19" designation exists, six conserved SARS-CoV-2 spike epitopes (e.g., S287–317, S614–640) were identified as highly immunogenic across variants . These regions are critical for broad-spectrum antibody therapies.

  • Hypothetical or Proprietary Nomenclature: The term may represent a non-standardized antibody designation, requiring clarification from the source.

SARS-CoV-2 Neutralizing Antibodies

AntibodyTargetKey FeaturesSources
SC27Spike proteinBroadly neutralizes all SARS-CoV-2 variants and SARS-like coronaviruses .
VYD2311Spike proteinPhase 1/2 data shows 17-fold greater neutralization potency vs. pemivibart .
LY3819253Spike proteinPhase 2/3 trials for mild-to-moderate COVID-19 .

Autoimmune Disease Antibodies

AntibodyTargetClinical RelevanceSources
Anti-SSPS. mutans MIPDistinguishes SLE from other autoimmune diseases (34.2% sensitivity) .
Anti-CD19B-cell surfaceDepletes B cells in systemic sclerosis; superior to anti-CD20 in some trials .

Antibody Structure and Mechanism

  • Fab Domain: Recognizes antigens via complementarity-determining regions (CDRs) .

  • Fc Domain: Mediates effector functions (e.g., complement activation, phagocytosis) .

  • Glycosylation: Critical for Fc receptor binding; human IgG1 Fc glycans include mannose, GlcNAc, and sialic acid .

Cross-Reactive Antibodies in COVID-19

  • Pre-existing CD4+ T cells: Recognize conserved spike epitopes (e.g., C-terminal regions) in 35% of healthy donors, likely from endemic coronaviruses .

  • Universal Vaccine Targets: Conserved spike epitopes (e.g., S614–640) elicit durable IgG responses across variants .

Neutralizing Antibody Testing

MethodTargetCorrelationSources
sVNT (surrogate)S-RBD bindingHigh correlation (ρ = 0.92) with standard VNT .
ELISAS-RBD IgGEstimates neutralization capacity .

Antibody Therapies in Development

TherapyRouteEfficacySources
VYD2311IM/SCPotential for annual dosing; superior safety vs. vaccines .
SC27IntravenousBroad neutralization across variants .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ssp-19 antibody; C55C2.2 antibody; Sperm-specific class P protein 19 antibody
Target Names
ssp-19
Uniprot No.

Q&A

What is ssp-19 and what function does it serve in C. elegans?

Ssp-19 (gene ID: 171813) is a protein expressed in Caenorhabditis elegans, commonly used as a model organism in developmental biology research. It belongs to the sperm-specific protein family, which plays roles in nematode reproduction and development. The protein is encoded by the ssp-19 gene, and its UniProt accession number is O01829 . The specific function of ssp-19 involves sperm cell maturation and motility, making it a valuable target for researchers studying reproductive biology in invertebrates.

What validation methods should be used to confirm ssp-19 antibody specificity?

Validation of ssp-19 antibody specificity should include multiple complementary techniques. First, researchers should perform Western blot analysis using both the recombinant immunogen protein (provided with the antibody) and wild-type C. elegans lysate to confirm the antibody recognizes the correct molecular weight band . Second, comparing signal patterns between wild-type and ssp-19 knockout or knockdown worms can provide definitive evidence of specificity. Third, immunoprecipitation followed by mass spectrometry can confirm target binding. The pre-immune serum provided with the antibody should be used as a negative control in all validation experiments to establish baseline reactivity .

What are the recommended storage conditions and handling procedures for the ssp-19 antibody?

The ssp-19 antibody should be stored at -20°C or -80°C for long-term preservation of activity . When handling the antibody, it's crucial to avoid repeated freeze-thaw cycles, which can lead to denaturation and loss of binding capacity. Aliquoting the antibody upon receipt is recommended to minimize freeze-thaw events. For short-term storage (1-2 weeks), keeping the antibody at 4°C with an appropriate preservative (such as 0.02% sodium azide) is acceptable. Always centrifuge the antibody vial briefly before opening to collect all liquid at the bottom of the tube. The antibody is shipped on blue ice, indicating its temperature sensitivity .

How should researchers optimize Western blot protocols specifically for ssp-19 antibody?

When optimizing Western blot protocols for ssp-19 antibody, researchers should consider the following methodological approaches:

  • Sample preparation: Extract proteins from C. elegans using a detergent-based lysis buffer containing protease inhibitors to prevent degradation.

  • Protein loading: Begin with 20-40 μg total protein per lane and adjust as needed based on expression levels.

  • Antibody dilution: Start with a 1:1000 dilution of the purified antibody and titrate to determine optimal concentration.

  • Blocking conditions: Use 5% non-fat dry milk or BSA in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature.

  • Primary antibody incubation: Incubate overnight at 4°C with gentle rocking.

  • Detection method: HRP-conjugated secondary antibodies with enhanced chemiluminescence generally provide good results.

  • Controls: Always include the recombinant immunogen protein as a positive control and pre-immune serum as a negative control .

The protein A/G purification method used for this antibody typically results in high specificity, which helps reduce background when following these recommendations .

What considerations are important when using ssp-19 antibody for immunohistochemistry in C. elegans tissues?

For immunohistochemistry applications with ssp-19 antibody, researchers should consider:

  • Fixation method: Paraformaldehyde (4%) is generally preferred, but comparison with other fixatives like Bouin's or methanol/acetone may be necessary.

  • Permeabilization: C. elegans cuticle is highly impermeable; therefore, freeze-crack or collagenase treatment methods are essential for antibody penetration.

  • Antibody concentration: Start with a higher dilution (1:100-1:200) than used for Western blotting.

  • Incubation conditions: Extend primary antibody incubation to 24-48 hours at 4°C to ensure tissue penetration.

  • Controls: Include wild-type and ssp-19 deficient worms as positive and negative controls, respectively.

  • Counterstaining: DAPI nuclear staining helps identify specific tissues and developmental stages.

  • Confocal microscopy: Use z-stack imaging to fully capture the three-dimensional expression pattern.

Since ssp-19 is expressed in reproductive tissues, special attention should be given to gonad dissection techniques to preserve tissue morphology while allowing antibody access.

How can the ssp-19 antibody be applied in studying protein-protein interactions in nematode reproduction?

The ssp-19 antibody can be effectively utilized in studying protein-protein interactions through several methodological approaches:

  • Co-immunoprecipitation (Co-IP): Using the protein A/G purified ssp-19 antibody to pull down ssp-19 protein complexes from C. elegans lysates, followed by mass spectrometry or Western blotting to identify interaction partners.

  • Proximity ligation assay (PLA): Combining ssp-19 antibody with antibodies against suspected interaction partners to visualize protein interactions in situ with spatial resolution.

  • FRET analysis: Combining immunofluorescence using ssp-19 antibody with fluorescently tagged potential binding partners.

  • Yeast two-hybrid validation: Using results from Y2H screens to guide Co-IP experiments with the ssp-19 antibody.

  • Cross-linking studies: Employing chemical cross-linkers before immunoprecipitation to capture transient interactions.

These approaches can reveal the molecular networks involved in nematode sperm function and maturation, potentially identifying conserved mechanisms relevant to reproductive biology across species.

What considerations are important when designing ELISA protocols using ssp-19 antibody?

When designing ELISA protocols using ssp-19 antibody, researchers should consider:

ParameterRecommendationRationale
Plate coating1-5 μg/ml of capture antibody or antigenEnsures sufficient binding without excess protein
Blocking buffer2-5% BSA in PBSReduces background while preserving antibody activity
Sample dilutionSerial dilutions starting at 1:10Allows for determination of optimal concentration
Antibody dilution1:500 to 1:2000Start with manufacturer's recommendation and optimize
Incubation time1-2 hours at room temperatureBalances sensitivity with practicality
Washing steps4-5 washes with PBS-TCrucial for reducing background signal
Detection systemHRP or AP-conjugated secondary antibodySelect based on desired sensitivity
SubstrateTMB for HRP, pNPP for APConsider readout equipment availability

When developing a sandwich ELISA, it's important to verify that the ssp-19 antibody doesn't interfere with epitope recognition when used as both capture and detection antibody. The recombinant immunogen protein provided with the antibody serves as an excellent positive control for establishing standard curves .

How can researchers address cross-reactivity concerns when studying ssp-19 homologs in related nematode species?

Addressing cross-reactivity concerns requires a systematic approach:

  • Sequence alignment analysis: Compare ssp-19 protein sequences across nematode species to identify conserved epitopes and potential cross-reactive regions.

  • Pre-adsorption controls: Incubate the antibody with recombinant ssp-19 protein before immunostaining to confirm signal specificity.

  • Western blot validation: Test the antibody against lysates from multiple nematode species to assess cross-reactivity patterns.

  • Epitope mapping: If persistent cross-reactivity occurs, identify the specific epitopes recognized by performing epitope mapping experiments.

  • Species-specific negative controls: Include tissues from species known not to express ssp-19 homologs.

  • Immunodepletion studies: Sequentially deplete the antibody against proteins from different species to determine specific versus cross-reactive binding.

While the ssp-19 antibody was raised against recombinant C. elegans protein , researchers should independently validate its reactivity when working with other invertebrate species, despite the "invertebrates" species reactivity listed by the manufacturer.

How should researchers interpret variations in ssp-19 antibody signal between different developmental stages of C. elegans?

Variations in ssp-19 antibody signal across developmental stages should be interpreted considering:

  • Developmental expression patterns: ssp-19 expression likely changes throughout development, particularly during reproductive maturation.

  • Protein localization changes: Subcellular distribution of ssp-19 may shift during development, affecting signal intensity and pattern.

  • Normalization methods: Always normalize to appropriate loading controls specific for each developmental stage.

  • Quantification approach: Use integrated density measurements rather than peak intensity for more accurate comparisons across stages.

  • Sample preparation consistency: Ensure identical fixation and permeabilization conditions for all developmental stages.

  • Time-course experiments: Perform detailed time-course studies to capture transitional expression patterns.

Researchers should complement antibody-based detection with mRNA expression analysis (RT-qPCR or in situ hybridization) to distinguish between transcriptional and post-transcriptional regulation across developmental stages.

What are the most common causes of non-specific binding with ssp-19 antibody and how can they be mitigated?

Common causes of non-specific binding and their mitigation strategies include:

  • Insufficient blocking: Increase blocking time (2-3 hours) or concentration (5% BSA or milk), or try alternative blocking agents like fish gelatin.

  • Excessive antibody concentration: Titrate antibody to determine the minimal effective concentration; typically starting with 1:1000 dilution and adjusting as needed.

  • Cross-reactive epitopes: Pre-adsorb the antibody with recombinant proteins containing similar epitopes or use the provided pre-immune serum to identify baseline non-specific binding .

  • Inadequate washing: Increase number and duration of washes; add 0.2-0.3% Triton X-100 to wash buffer for better removal of unbound antibody.

  • Sample overloading: Reduce protein concentration in Western blots or cell density in immunocytochemistry.

  • Denatured antibody: Avoid repeated freeze-thaw cycles and maintain appropriate storage conditions (-20°C or -80°C) .

  • Protein A/G leakage: If background persists, consider additional purification steps beyond the manufacturer's protein A/G purification .

Always include the pre-immune serum control provided with the antibody to establish baseline reactivity for each experimental condition .

How can researchers effectively compare data from experiments using different detection methods (fluorescence vs. chromogenic) with ssp-19 antibody?

When comparing data from different detection methods, researchers should:

  • Establish calibration curves: Use the provided recombinant immunogen protein to create standard curves for both detection methods .

  • Normalize to consistent controls: Include identical positive and negative controls across all experiments.

  • Account for detection limitations: Understand the linear detection range for each method (fluorescence typically offers wider dynamic range).

  • Use internal reference standards: Include calibrated reference samples in each experiment to allow for inter-experimental normalization.

  • Apply appropriate statistical methods: Use methods that account for the different error distributions inherent to each detection system.

  • Consider signal amplification differences: Enzymatic amplification (HRP) versus direct fluorescence have fundamentally different signal generation mechanisms.

  • Document exposure/gain settings: Maintain detailed records of all instrument settings to ensure reproducibility.

Converting between methods may require establishing conversion factors through parallel processing of identical samples using both detection methods simultaneously.

How does the performance of ssp-19 antibody compare with RNA interference approaches for studying ssp-19 function?

Both antibody-based detection and RNAi approaches offer complementary insights into ssp-19 function:

Parameterssp-19 AntibodyRNAi Approach
Detection levelProteinmRNA
Temporal resolutionCaptures post-translational eventsLimited to transcriptional effects
Spatial informationProvides subcellular localizationTypically whole-organism effects
QuantificationDirect measurement of protein levelsIndirect assessment of function
Technical challengesPotential cross-reactivity issuesOff-target effects, variable knockdown
Tissue specificityCan detect in specific tissuesOften affects multiple tissues unless controlled
Developmental stagesCan examine in fixed samplesRequires stage-specific delivery
Cost considerationsHigher per-experiment costLower recurring costs after initial setup

For comprehensive studies, researchers should combine both approaches: use RNAi to modulate ssp-19 expression and the antibody to confirm knockdown at the protein level and examine consequences on localization and interaction partners.

What are the advantages and limitations of using the ssp-19 antibody compared to genetic reporters (GFP fusions) for protein localization studies?

Using ssp-19 antibody versus GFP fusion proteins for localization studies presents distinct advantages and limitations:

Advantages of ssp-19 antibody:

  • Detects endogenous protein without overexpression artifacts

  • Doesn't require genetic modification of the organism

  • Can detect post-translational modifications with modification-specific antibodies

  • Not affected by GFP misfolding or interference with protein function

  • Can be applied to preserved specimens and clinical samples

Limitations of ssp-19 antibody:

  • Requires fixation, potentially introducing artifacts

  • Limited to endpoint analysis (no live imaging)

  • Potential cross-reactivity with related proteins

  • Signal amplification may obscure fine localization details

  • Requires permeabilization, which can disrupt some cellular structures

For optimal experimental design, researchers might consider using both approaches in parallel: GFP fusions for live dynamics and antibody detection for validation of endogenous protein patterns, especially when studying dynamic processes in reproductive tissues where ssp-19 is likely expressed.

How might the ssp-19 antibody be utilized in comparative studies across evolutionarily diverse nematode species?

The ssp-19 antibody offers potential applications in evolutionary studies across nematode species:

  • Conservation mapping: By testing reactivity across species, researchers can map the evolutionary conservation of ssp-19 epitopes.

  • Functional divergence studies: Different binding patterns may reveal functional adaptations in reproductive proteins across ecological niches.

  • Phylogenetic analysis: Antibody reactivity patterns could complement molecular phylogeny in resolving nematode evolutionary relationships.

  • Structural biology applications: Differential binding across species can highlight structurally conserved versus variable domains.

  • Adaptation mechanisms: Comparing expression patterns in free-living versus parasitic nematodes may reveal adaptive specializations.

Methodologically, researchers should perform careful sequence alignment of ssp-19 homologs across species, followed by Western blot validation against protein extracts from diverse nematodes. Immunohistochemistry can then be applied to compare localization patterns, potentially revealing evolutionary shifts in protein function or regulation.

What emerging technologies might enhance the application of ssp-19 antibody in reproductive biology research?

Several emerging technologies could significantly enhance ssp-19 antibody applications:

  • Super-resolution microscopy: Techniques like STORM or PALM could reveal nanoscale localization patterns beyond the diffraction limit.

  • Spatial transcriptomics integration: Combining ssp-19 immunohistochemistry with spatial transcriptomics could correlate protein localization with local gene expression landscapes.

  • Proximity labeling: Using ssp-19 antibody conjugated to enzymes like APEX2 or BioID to identify proximal proteins in living cells.

  • Single-cell proteomics: Integrating antibody-based detection with single-cell protein analysis to reveal cell-to-cell variability in ssp-19 expression.

  • Organ-on-chip technologies: Applying ssp-19 antibody in microfluidic reproductive tract models to study dynamic protein function.

  • CRISPR epitope tagging: Using precise genome editing to introduce small epitope tags for orthogonal validation of antibody specificity.

  • Computational antibody epitope prediction: Using AI algorithms to predict cross-reactivity and optimal application conditions.

These technologies could provide unprecedented insights into ssp-19 function in reproductive processes, potentially revealing conserved mechanisms relevant to fertility research across species.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.